[Attempts to prevent intrauterine growth retardation using platelet anti-aggregants].
Intrauterine underdevelopment is a frequent complication in pregnancies associated with high blood pressure. It can also happen in the absence of this symptom but in a similar context. During these pregnancies, homeostasis problems were often shown to be at the root of placental abnormalities responsible for the development problems. This is why the authors of this article have tried to prevent intrauterine underdevelopment by prescribing antiplatelet drugs as from the start of the 2nd trimester of pregnancy. They compare their encouraging results with those of other teams and conclude that a larger prospective trial is necessary.
Uzan
S
S
Clinique Universitaire Guy Le Lorier, Hôpital Tenon, Paris.
Beaufils
M
M
D005260:Female; D005317:Fetal Growth Retardation / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000150:complications; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular
D010975:Platelet Aggregation Inhibitors
Tentatives de prévention des retards de croissance intra-utérins par les anti-agrégants plaquettaires.